Omnilink Elite 1012623-19Recalls & reported problems
Abbott Vascular Inc. · Omnilink Elite Vascular Balloon-Expandable Stent System 7.0 mm x 19 mm x 80 cm Over-The-Wire · Class 3 · Implant
All models of Omnilink Elite (42)
Data updated Oct 18, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 4
- Deaths reported
- 0
- Injuries reported
- 4
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 4 adverse event reports that list this exact device (DI 08717648179242), received between Dec 16, 2016 and Jan 27, 2022 — classified as 4 injuries.
The most frequently reported specific device problem is “Device Dislodged or Dislocated” (2 reports).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem2
- Device Dislodged or Dislocated2
- Difficult to Advance1
- Improper or Incorrect Procedure or Method1
- Inflation Problem1
- Off-Label Use1
Patient problems
- Fistula1
- Hypersensitivity/Allergic reaction1
- No Consequences Or Impact To Patient1
- Numbness1
- Pain1
- Perforation1
- Vascular Dissection1
Recent adverse event reports
The 4 most recent of 4 reports, in the reporter's own words as published by the FDA.
InjuryJan 27, 2022Difficult to Advance; Device Dislodged or Dislocated; Difficult to Advance; Device Dislodged or Dislocated
IT WAS REPORTED THAT ON (B)(6) 2021, THE PROCEDURE WAS TO TREAT A 90% STENOSED LESION IN THE LEFT EXTERNAL ILIAC ARTERY. ACCESS WAS GAINED VIA RIGHT ILIAC ARTERY AND A 7X19MM OMNI ELITE VASCULAR BALLOON-EXPANDABLE STENT SYSTEM (BES) WAS ADVANCED THROUGH THE 6F SHEATH WITH RESISTANCE. THE STENT BECAME DISLODGED FROM THE CATHETER INTO THE RIGHT ILIAC. SEVERAL ATTEMPTS WERE MADE TO CAPTURE THE STENT WITH A 4MM SNARE BUT WERE UNSUCCESSFUL. THE PATIENT WAS TAKEN TO SURGERY, WHERE IT WAS NOTED THAT THERE WAS A DISSECTION AND AN AV FISTULA AS WELL. THE SURGICAL PHYSICIAN MADE A SMALL INCISION, REMOVED THE STENT IN PIECES FROM SUBCUTANEOUS TISSUE AND REPAIRED THE DISSECTION IN THE ARTERY. THE AV FISTULA DID NOT REQUIRE TREATMENT AND REPAIRED ITSELF. THE PATIENT WAS DISCHARGED TO HOME ON (B)(6) 2022. THERE WAS NO ADVERSE PATIENT SEQUELA AND NO REPORTED CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE OR THERAPY. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Fistula; Vascular Dissection
MAUDE report 13367449 ↗InjuryJan 21, 2020Off-Label Use; Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem; Off-Label Use; Improper or Incorrect Procedure or Method; Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THAT THE PROCEDURE WAS PERFORMED TO TREAT THE EXTERNAL ILIAC ARTERY. THE 7.0X19MM OMNILINK ELITE STENT WAS DEPLOYED. POST DEPLOYMENT, THE PHYSICIAN FELT HE HAD PLACED THE STENT TOO HIGH AND DECIDED TO PLACE AN UNSPECIFIED BALLOON IN THE DEPLOYED STENT AND PULL DOWN WHICH CAUSED A PERFORATION. THE PERFORATION WAS TREATED USING AN UNSPECIFIED COVERED STENT INSIDE THE OMNILINK STENT. THERE WAS NO ADVERSE PATIENT SEQUELA REPORTED. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Perforation
MAUDE report 9611429 ↗InjuryJan 31, 2019Inflation Problem; Device Dislodged or Dislocated; Inflation Problem; Device Dislodged or Dislocated
IT WAS REPORTED THAT THE PROCEDURE WAS TO TREAT AN ILIAC ARTERY. A 7.0X19MM OMNILINK ELITE STENT DELIVERY SYSTEM WAS ADVANCED TO THE LESION BUT COMPLETELY FAILED TO INFLATE. DURING REMOVAL OF THE DEVICE THE STENT DISLODGED IN THE ILIAC ARTERY. NO RESISTANCE WAS MET DURING REMOVAL. AS THE STENT HAD DISLODGED PARTIALLY COVERING THE LESION AND PARTIALLY COVERING HEALTHY TISSUE, IT WAS DECIDED TO USE ANOTHER BALLOON TO DILATE THE DISLODGED STENT AND APPOSE IT TO THE VESSEL WALL. THEN ANOTHER STENT WAS USED AND IMPLANTED DISTAL TO THE DISLODGED STENT TO TREAT THE INITIAL LESION LOCATION. THERE WERE NO ADVERSE PATIENT EFFECTS AND NO CLINICALLY SIGNIFICANT DELAY IN THE PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 8292845 ↗InjuryDec 16, 2016Adverse Event Without Identified Device or Use Problem
IT WAS REPORTED THE PATIENT HAD THREE OMNI ELITE AND ONE ABSOLUTE PRO STENTS IMPLANTED IN THE RIGHT COMMON ILIAC AND LEFT COMMON ILIAC ARTERIES ON (B)(6) 2013. APPROXIMATELY A YEAR LATER, THE PATIENT STARTED EXPERIENCING TINGLING AND SEVERE PAIN DOWN BOTH LEGS. MEDICATION HAS BEEN PRESCRIBED. THE PATIENT HAS ALWAYS BEEN SENSITIVE TO METAL; THEREFORE, AN ALLERGY KIT HAS BEEN REQUESTED BY THE ALLERGIST. ADDITIONALLY, THE PATIENT SUFFERS OF AN OCCLUSIVE PERIPHERAL DISEASE. NO ADDITIONAL INFORMATION WAS PROVIDED.
Patient problems: Hypersensitivity/Allergic reaction; Numbness; Pain
MAUDE report 6182549 ↗
Other STENT, ILIAC devices
- Cordis S.M.A.R.T. Control Vascular Stent System C10040MLCordis US Corp. · STENT, ILIAC1 recall3 reports
- Absolute Pro 1012534-100Abbott Vascular Inc. · STENT, ILIAC51 reports
- Protégé™ GPS™ SERB65-09-60-80Ev3, Inc · STENT, ILIAC1 recall0 reports
- Cordis S.M.A.R.T. Control Vascular Stent System C09060MLCordis US Corp. · STENT, ILIAC1 recall0 reports
- Absolute Pro 1012535-100Abbott Vascular Inc. · STENT, ILIAC1 death41 reports
- Omnilink Elite 1012631-39Abbott Vascular Inc. · STENT, ILIAC27 reports
- Omnilink Elite 1012632-29Abbott Vascular Inc. · STENT, ILIAC25 reports
- Absolute Pro 1012536-100Abbott Vascular Inc. · STENT, ILIAC21 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page